Screening for cognitive impairment, Alzheimer’s disease and other dementias: Opinions of European caregivers, payors, physicians and the general public

被引:0
|
作者
John Bond
N. Graham
A. Padovani
J. Mackell
S. Knox
J. Atkinson
机构
[1] Newcastle University,Institute of Health and Society and Institute for Ageing and Health
[2] Alzheimer’s Disease International,Department of Medical and Surgical Sciences
[3] Università degli Studi di Brescia,undefined
[4] Pfizer Inc,undefined
[5] Eisai Europe Ltd.,undefined
[6] Pfizer Ltd,undefined
[7] Newcastle University,undefined
关键词
Alzheimer’s disease; screening; early diagnosis; physicians; caregivers; payors; general public;
D O I
暂无
中图分类号
学科分类号
摘要
The IMPACT survey queried physicians, caregivers, payors and members of the general public from 5 European countries (France, Germany, Italy, Spain and the United Kingdom) regarding their opinions towards screening for Alzheimer’s disease (AD) as part of a 30-minute Web-based questionnaire conducted between April and May 2009. A larger proportion of caregivers (84%) and members of the general public (80%) than of physicians (56%) or payors (40%) viewed routine screening for AD as extremely or very important (P<0.001 for caregivers or general public vs physicians or payors). When asked if everyone should be routinely screened for AD at age 65, a smaller proportion of physicians (42%) and payors (44%) than members of the general public (81%) or caregivers (80%) agreed (P<0.001 for caregivers or general public vs physicians or payors). These opinions were generally consistent across the 5 countries for each respondent group. A notable exception was physician respondents from Italy, where most generalists and specialists actually favoured screening. Overall, generalists had a more positive attitude towards screening than specialists. The most frequently cited reason given by those who did not favour routine screening at age 65 was screening inaccuracy. This article discusses these results in relation to what screening is, when to screen and the barriers to screening. Despite the majority of IMPACT respondents being in favour of screening for AD, the evidence to support the introduction of population screening for cognitive impairment is not available; however, the importance of optimal identification of AD and other dementias in primary care should be a priority for community health professionals and payors. In order to do this effectively, further work is required to identify good assessment guidelines for use during opportunistic screening for cognitive impairment in primary care.
引用
收藏
页码:558 / 562
页数:4
相关论文
共 50 条
  • [1] Screening for cognitive impairment, Alzheimer's disease and other dementias: Opinions of European caregivers, payors, physicians and the general public
    Bond, J.
    Graham, N.
    Padovani, A.
    Mackell, J.
    Knox, S.
    Atkinson, J.
    JOURNAL OF NUTRITION HEALTH & AGING, 2010, 14 (07): : 558 - 562
  • [2] TRANSITIONS IN COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE AND OTHER DEMENTIAS
    不详
    GERONTOLOGIST, 2009, 49 : 87 - 87
  • [3] Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias
    Payne, JL
    Lyketsos, CG
    Steele, C
    Baker, L
    Galik, E
    Kopunek, S
    Steinberg, M
    Warren, A
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1998, 10 (04) : 440 - 447
  • [4] Cognitive pharmacotherapy of Alzheimer's disease and other dementias
    Herrmann, N
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (08): : 715 - 722
  • [5] Treatment of cognitive deficits in Alzheimer's Disease and other dementias
    Hefting, N. R.
    NORDIC JOURNAL OF PSYCHIATRY, 2007, 61 (06) : 492 - 492
  • [6] Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Lives of Lesbian, Gay, Bisexual and Transgender (LGBT) Older Adults and Their Caregivers: Needs and Competencies
    Fredriksen-Goldsen, Karen I.
    Jen, Sarah
    Bryan, Amanda E. B.
    Goldsen, Jayn
    JOURNAL OF APPLIED GERONTOLOGY, 2018, 37 (05) : 545 - 569
  • [7] Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias
    Davis, Daniel H. J.
    Creavin, Sam T.
    Yip, Jennifer L. Y.
    Noel-Storr, Anna H.
    Brayne, Carol
    Cullum, Sarah
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (10):
  • [8] Genetic counselling and genetic screening for Alzheimer's disease and other dementias
    Sadovnick, AD
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2001, 28 : S52 - S55
  • [9] Perceived Threat of Alzheimer's Disease and Related Dementias Among Chinese Family Caregivers of Older Adults with Cognitive Impairment
    Chen, Yaofeng
    Gao, Xiang
    Sun, Fei
    JOURNAL OF GERONTOLOGICAL SOCIAL WORK, 2024, 67 (07): : 976 - 994
  • [10] Burden and anticipatory grief in caregivers of family members with Alzheimer's disease and other dementias
    Perez-Gonzalez, Alba
    Vilajoana-Celaya, Josep
    Guardia-Olmos, Joan
    PALLIATIVE & SUPPORTIVE CARE, 2023,